The Burden of Childhood Asthma Arch Dis Child: First Published As 10.1136/Adc.82.Suppl 2.Ii2 on 1 June 2000

Total Page:16

File Type:pdf, Size:1020Kb

The Burden of Childhood Asthma Arch Dis Child: First Published As 10.1136/Adc.82.Suppl 2.Ii2 on 1 June 2000 ii2 Arch Dis Child 2000;82(Suppl II):ii2–ii5 The burden of childhood asthma Arch Dis Child: first published as 10.1136/adc.82.suppl_2.ii2 on 1 June 2000. Downloaded from Erika von Mutius Abstract Prevalence of childhood asthma and Paediatric asthma is a major clinical con- associated symptoms cern worldwide and represents a huge The ISAAC study compared the prevalence burden on family and society. It accounts rates of asthma and atopic disease in 155 cen- for a large number of lost school days and tres in 56 countries worldwide, and was may deprive the child of both academic conducted over a period of one year in 721 601 3 achievement and social interaction. children aged either 6–7 years or 13–14 years. Childhood asthma also places strain on Overall, the prevalence of asthma tended to be healthcare resources as a result of doctor greater in English speaking countries, but the and hospital visits and the cost of treat- international pattern was suggestive that envi- ment. The prevalence of asthma varies ronmental factors may have played a role in the worldwide, possibly because of diVerent prevalence of childhood asthma. exposure to respiratory infection, indoor Evidence from the ISAAC study also showed and outdoor pollution, and diet. Certain that the distribution of childhood asthma varies between global populations from less than 2% risk factors appear to predispose children to approximately 33% of the population. to developing asthma and atopic disease, Prevalence reaches 17–30% in the UK, New including incidence and severity of wheez- Zealand, and Australia, whereas areas of low ing, atopy, maternal smoking, and prevalence (1–7%) include Eastern Europe, number of fever episodes. This paper dis- China, and Indonesia.3 Furthermore, the cusses the burden, prevalence, and risk prevalence also appears to vary within coun- factors associated with paediatric asthma. tries. For example, across India it ranges from (Arch Dis Child 2000;82(Suppl II):ii2–ii5) less than 5% to approximately 20%.3 Keywords: asthma; disease prevalence; burden of It is unclear why the variation in the disease; risk factors prevalence of asthma is so large. One theory involves a greater understanding of hygiene and healthcare in the western world, which Asthma is the most common chronic disease in may lead to a diVerent exposure to infection children. The prevalence is increasing although early in life. Consequently, this may render the the reasons why are poorly understood. Paedi- immune system susceptible to an atopic atric asthma is a major global health problem, response.4 Childhood respiratory disease,5 al- which exerts a substantial burden on the lergen exposure,6 dietary changes,78and socio- http://adc.bmj.com/ 9 family, healthcare services, and on society as a economic diVerences may also play a role in whole. A national survey of over 17 000 house- the variation. holds in the United States showed that the Ethnic origin may also play a role in the annual burden experienced by 2.7 million chil- prevalence of asthma. This was confirmed in a dren aVected with asthma comprised 7.3 mil- recent study conducted in German children, of lion days when the patient was restricted to which 7% were either of Turkish nationality born in Germany or had moved there during on September 24, 2021 by guest. Protected copyright. bed, 10.1 million days of school absence, 12.9 10 million contacts with a doctor, and 200 000 the first year of life. The prevalence of asthma, hospitalisations resulting in 1.9 million days of atopy, and bronchial hyperresponsiveness were lower in Turkish children than in native hospital admissions.1 Furthermore, asthma can German children. Multivariable analysis failed considerably impair the child’s ability to enjoy to highlight any of the risk factors assessed, and partake in activities such as playing a although other factors that were not evaluated, musical instrument and sporting events,2 and such as diet may explain the diVerence between even aVect sleep patterns and their academic the populations. A genetic factor is unlikely to and career success because of poor school be involved, as the prevalence of asthma in attendance associated with asthma attacks. In Turkish children living in Germany was lower addition, cancellation of social events because than that reported in Turkey. Alternatively, of illness and sibling rivalry may aVect families some type of selection bias associated with of the asthmatic child. immigration, for example, only healthy Turkish The common characteristics of asthma people chose to move to Germany, may be include bronchospasm, variable airway nar- implicated. rowing, bronchial hyperresponsiveness, and Following the reunification of Germany in University Children’s airway inflammation, but its diagnostic defini- Hospital, 1989, various epidemiological comparative Lindwurmstr. 4, tion is still not clearly defined. Asthma studies examined whether environmental and D-80337 Munich, prevalence studies lack consistency, possibly cultural diVerences play a role in disease preva- Germany because of the ill defined diagnostic criteria lence in the former East and West Germany. E von Mutius and non-standardised study protocols. Conse- Children who lived in the former East Correspondence to: quently, an international study was performed Germany have a significantly lower prevalence Dr von Mutius using a standardised protocol for each centre.3 of asthma and hay fever (fig 1), despite being The burden of childhood asthma ii3 Arch Dis Child: first published as 10.1136/adc.82.suppl_2.ii2 on 1 June 2000. Downloaded from 14 childhood respiratory disorders, their progno- sis, and the development of asthma. Martinez 12 and colleagues14 studied 1246 newborn babies 10 during the first six years of life and examined the pattern of wheezing and its associated fac- 8 * tors. By the age of 6, 52% of children had never had any wheezing compared with 20% who 6 had transient early wheezing before the age of 3, 15% began to wheeze after the age of 3 (late 4 † onset wheezers), and 14% experienced wheez- 2 ing throughout their first six years (fig 2). Fur- thermore, 60% of those children who wheezed Prevalence of atopic disease (%) 0 Asthma Hay fever before the age of 3 were reported to be wheeze Figure 1 Prevalence of atopic diseases in Munich, free by the age of 6. When the incidence of Leipzig, and Halle. Open and closed columns refer to wheezing with respect to age was evaluated, Munich and Leipzig/Halle. Statistical comparisons were certain risk factors were found to be associated performed: *p < 0.05; †p < 0.0005 (data from von Mutius et al11). with transient, late onset and persistent wheez- ing. 60 Risk factors associated with transient wheez- ing included small airways and impaired lung 50 function at birth, whereas maternal asthma, 40 atopy, and male sex appeared to predispose for 30 both late onset and persistent wheezing. Impaired lung function at 6 years, increased 20 IgE concentrations at 9 months, maternal 10 smoking, and eczema during the first year of 0 life were also linked to persistent wheezing Proportion of patients (%) (table 1). Impaired lung function at 6 years probably reflects the chronic nature of persist- Transient Late onset Persistent No wheeze ent wheezing. Martinez and colleagues14 sug- wheeze: 0–3 y wheeze: 3–6 y wheeze: 3–6 y gested that children may have become sensi- Figure 2 Patterns of wheezing in 1246 newborn babies tised below the age of 1, thus contributing to during the first six years of life (data from Martinez et persistent wheezing, as IgE concentrations at 14 al ). the age of 9 months correlated with persistent wheezing. exposed to higher levels of atmospheric 15 pollution.11 In contrast, the prevalence of bron- Stein and colleagues examined the relation chitis, frequent cough, and wheeze were greater between lower respiratory tract illness before in the former East than the West, possibly the age of 3 and the prevalence of atopy and wheezing in childhood. Of the 1246 children because of the prevalence of viral infection in http://adc.bmj.com/ day care and/or to higher pollution levels in the enrolled at birth, 888 were followed up over the East. However, by the mid 1990s, the preva- first three years of life. The results showed that lence of childhood hay fever and atopic sensiti- those children who experienced a lower sation increased in the former East part of respiratory tract infection because of respira- Germany, while the prevalence of asthma tory syncytial virus had a greater risk of subse- remained stable.8 The findings further indicate quent wheezing in the first six years of life, but that factors aVecting the onset of asthma may this risk had disappeared by the age of 11. In be prevalent during the early infant years, addition, no association was found between the on September 24, 2021 by guest. Protected copyright. whereas the development of hay fever and incidence of respiratory syncytial virus infec- atopic sensitisation appears to be under the tion and the subsequent development of aller- control of factors associated with the post- gic disease. infancy age. Relation between infantile fever and Wheezing illness in childhood childhood asthma Approximately 70% of wheezing episodes dur- Infection with rhinoviruses, respiratory syncy- ing the first year are associated with viral respi- tial virus, parainfluenza virus, or coronavirus ratory infection,12 of which respiratory syncy- causes 50–60% of exacerbations among asth- matic patients; however, the type of infection tial virus, rhinovirus, and
Recommended publications
  • Original Articles International Patterns of Tuberculosis and the Prevalence of Symptoms of Asthma, Rhinitis, and Eczema
    Thorax 2000;55:449–453 449 Original articles Thorax: first published as 10.1136/thorax.55.6.449 on 1 June 2000. Downloaded from International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema Erika von Mutius, Neil Pearce, Richard Beasley, Soo Cheng, Ondine von Ehrenstein, Bengt Björkstén, Stephan Weiland, on behalf of the ISAAC Steering Committee Abstract national patterns of the prevalence of these Background—An ecological analysis was diseases2 are largely unknown. In particular, conducted of the relationship between they cannot be explained by the established tuberculosis notification rates and the putative risk factors such as allergen exposure prevalence of symptoms of asthma, aller- and air pollution which do not appear to be gic rhinoconjunctivitis, and atopic eczema strongly related to the underlying population in 85 centres from 23 countries in which prevalence.2–5 This has led to consideration of standardised data are available. These factors that may programme the initial suscep- essentially comprised countries in Europe tibility to asthma and/or atopy which have as well as the USA, Canada, Australia, and changed in temporal association with the New Zealand. increasing trends in prevalence worldwide, are Methods—Tuberculosis notification rates consistent with international prevalence pat- were obtained from the World Health terns, and for which biological plausibility exists Organization. Data on the prevalence of with respect to an underlying mechanism. symptoms of asthma, rhinitis, and eczema One such hypothesis is that the lack of expo- in 235 477 children aged 13–14 years were sure in early childhood to infections such as University Children’s based on the responses to the written and tuberculosis, measles, and diphtheria may Hospital, Klinikum video questionnaires from the Inter- increase the risk of developing atopic disorders http://thorax.bmj.com/ Innenstadt, Munich, national Study of Asthma and Allergies in 67 Germany such as asthma.
    [Show full text]
  • Gene-Environment Interactions in Chronic Inflammatory Disease
    commentarY Gene-environment interactions in chronic inflammatory disease Harald Renz, Erika von Mutius, Per Brandtzaeg, William O Cookson, Ingo B Autenrieth & Dirk Haller Chronic inflammatory diseases represent a major challenge for both clinical research and patient care, and evidence indicates that these disorders develop as a result of complex gene-environment interactions. Better understanding of their cause-and-effect relationship is the basis for emerging proposals for therapy and prevention. ince the end of World War II there has been The European Science Foundation brought polymorphisms, which has shown that there Sa substantial increase in the incidence of together an international group of experts on are overlapping susceptibility genes in these chronic inflammatory disease that seems to fol- subjects ranging from epidemiology to epigenet- inflammatory disorders3. A prototypic example low a geographical pattern of industrialization ics for a 5-day meeting (19–22 October 2010) in is the discovery of polymorphisms in ORMDL3 and urban living1. This includes allergic condi- Barcelona, Spain2, intended to help define stra- in both asthma and IBD4,5. tions (asthma, allergic rhinoconjunctivitis, food tegic directions for research into this increasing Despite the identification of many potential allergies and eczema), as well as autoimmune public health concern. In this first meeting of the susceptibility genes6,7, their individual effects disorders such as type 1 diabetes, chronic inflam- Forward Look initiative of the European Science seem to be quite modest. Thus, for many dis- matory bowl disease (IBD) and neurodegenera- Foundation, discussions focused on the grand eases, the alleles that have been identified by tive disease. Genetics cannot account for the challenges that face research into gene-envi- genome-wide association studies explain only increase in prevalence over time (Fig.
    [Show full text]
  • Childhood Allergies and Asthma: New Insights
    Available online at www.sciencedirect.com ScienceDirect Childhood allergies and asthma: New insights on environmental exposures and local immunity at the lung barrier 1 1,2 Hermelijn H Smits , Lucie¨ n EPM van der Vlugt , 3,4 2 Erika von Mutius and Pieter S Hiemstra While certain bacteria and respiratory viruses promote local mucus-producing goblet cells and club cells. It not only inflammation and disease onset, a more diverse colonization of acts as a selective physical barrier against inhaled com- the different species in the (gut) microbiome may be linked to ponents, but is also actively involved in host defense, more regulatory responses and protection against asthma and inflammation and immunity [1]. This is illustrated by the allergies. These processes are also influenced in part by food ability of airway epithelial cells to mount robust antimi- intake, both targeting the composition of the gut microbiome crobial responses, produce pro-inflammatory mediators and influencing the immune system via metabolites. Early life and contribute to resolving inflammation. Airway epithe- environmental microbial exposure also contributes to lial cells are also actively involved in regulation of adap- protection against asthma and allergy and is linked with an tive immunity, and may orchestrate Th2 immunity and early activation of the innate immune system and the tolerance in allergy and asthma by for example recruiting development of regulatory immune responses. Although and activating dendritic cells (DC) and type 2 innate greater mechanistic insight is needed, it is tempting to lymphoid cells (ILC2) [2]. Recent studies have highlight- speculate that part of the environmental effect can be ed a role for the epithelial barrier and its interaction with explained by modulation of the microbiome composition at the innate immune system in preventing or reducing mucosal surfaces, epithelial barrier function and/or local allergic and/or asthmatic symptoms [3,4].
    [Show full text]
  • Series Asthma 2020 1 Primary Prevention of Asthma: from Risk and Protective Factors to Targeted Strategies for Prevention Rachel
    20TL11343 THELANCET-D-20-11343R1 Series [PII_REPLACE] Rachel B Embargo: September 7, 2020—23:30 (BST) This version saved: 11:07, 04-Sep-20 Doctopic: Review and Opinion Asthma 2020 1 Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention Erika von Mutius, Hermelijn H Smits Asthma is a complex disease that often starts in childhood. Genomic and environmental factors as well as aberrant Published Online immune maturation early in life can contribute to the onset of disease, with great disparity over time and geographical September 7, 2020 https://doi.org/10.1016/ regions. Epidemiological studies have scrutinised environmental exposures and attempted to translate these PII exposures into prevention strategies. Some approaches for patients with asthma have been successful (eg, smoking See Comment Lancet Respir Med ban, the Finnish Asthma Programme), and primary prevention of wheeze in pre-school children (age 0–5 years) by 2020; published online Sept 7. the supplementation of vitamin D or fish oil, or both, to pregnant women seems promising. Several recent prevention http://dx.doi.org/10.1016/ initiatives are based on strong asthma-protective environmental microbial exposures associated with traditional rural S2213-2600(20)30400-8 lifestyles. Preclinical studies with various bacterial lysates, bacterial and dietary metabolites, or helminthic compounds This is the first in a Series of have yielded promising results that await translation into clinical practice. Given the immense societal and individual three papers about reducing the burden of asthma burden of asthma, there is an urgent need to further develop novel strategies to eradicate the disease.
    [Show full text]
  • The Interrelations Between the Skin Microbiota, Allergic Diseases and Exposure to Microbes in Residential Environments
    The biodiversity hypothesis of allergy: The interrelations between the skin microbiota, allergic diseases and exposure to microbes in residential environments JENNI LEHTIMÄKI LUOVA - Doctoral Programme in Wildlife Biology Research Department of Biosciences, Faculty of Biological and Environmental Sciences University of Helsinki ACADEMIC DISSERTATION To be presented for public examination with the permission of the Faculty of Biological and Environmental Sciences of the University of Helsinki in Lecture hall 2, Infocenter Korona (Viikinkaari 11), on December 1st at 12.00 o’clock noon. HELSINKI 2017 SUPERVISED BY: Professor Ilkka Hanski (2014-2016) University of Helsinki Docent Lasse Ruokolainen University of Helsinki Professor Tiina Laatikainen National Institute for Health and Welfare; University of Eastern Finland MEMBERS OF THE THESIS ADVISORY COMMITTEE: Professor Tari Haahtela Helsinki University Central Hospital Docent Kimmo Saarinen Allergy and Asthma Federation Research Unit REVIEWED BY: Professor Erika von Mutius Munich University Children's Hospital Docent Anne Salonen University of Helsinki EXAMINED BY: Professor Harald Renz Philipps University of Marburg CUSTOS: Assistant Professor Arild Husby University of Helsinki ISBN 978-951-51-3837-8 (paperback) ISBN 978-951-51-3838-5 (PDF) http://ethesis.helsinki.fi Unigrafia Helsinki 2017 To all children, parents, dogs, dog owners, and daycare-workers who made this possible. Contents ABSTRACT 6 TIIVISTELMÄ 7 SUMMARY 9 1. INTRODUCTION ................................................................................................................................
    [Show full text]
  • German Center for Lung Research ANNUAL REPORT
    German Center for Lung Research ANNUAL REPORT 2017 Translational Research to Combat Widespread Lung Diseases Table of Contents Foreword 2 About the DZL: Science – Translation in the Focus of Research 3 Disease Areas 4 Asthma and Allergy 4 Chronic Obstructive Pulmonary Disease (COPD) 6 Cystic Fibrosis (Mucoviscidosis) 8 Pneumonia and Acute Lung Injury 10 Diffuse Parenchymal Lung Disease (DPLD) 12 Pulmonary Hypertension 14 End-Stage Lung Disease 16 Lung Cancer 18 Platforms and Infrastructure 20 Biobanking & Data Management Platform 20 Imaging Platform 22 DZL Technology Transfer Consortium 25 Clinical Trial Board and Clinical Studies in the DZL 26 DZL Collaborations, Partnerships, and Networks 28 Promotion of Junior Scientists and Equal Opportunities 34 The Public Face of the DZL 36 Highlights of the Year 2017 40 The German Centers for Health Research 43 DZL Organization 44 Selected Prizes and Awards 46 DZL Member Institutions and Sites 47 Finance and Personnel 53 1 Foreword Prof. Dr. Werner Seeger Prof. Dr. Hans-Ulrich Prof. Dr. Klaus F. Rabe Prof. Dr. Erika v. Mutius Prof. Dr. Tobias Welte Chairman of the Board Kauczor Board Member Board Member Board Member Board Member The anniversary year 2016 let us gain insights into the great research efforts of the scientists at the partner institutions through- out Germany, whose achievements are already put into practice in numerous occasions for the prevention, diagnosis, and treat- ment of lung diseases. 2017 lets us now look further ahead, taking a closer look at the promising future of the German Center for Lung Research (DZL). In summer 2017, the German Centers for Health Research (DZG) received a great accolade from the German Council of Scienc e and Humanities (Wissenschaftsrat) with its “Recommendations for the Further Development of the DZG”.
    [Show full text]
  • Forschungsbericht 2015/2016 2 Inhaltsverzeichnis
    FORSCHUNGSBERICHT 2015/2016 2 Inhaltsverzeichnis Vorwort ���������������������������������������������������������������������������������������������5 Priority Research Area Infections Leibniz Lungenzentrum - nomen est omen - �����������������������������������6 Bioanalytical Chemistry ������������������������������������������������������������������74 EvoLUNG �����������������������������������������������������������������������������������������10 Biophysics ����������������������������������������������������������������������������������������78 Postdocs - zwischen Baum und Borke? �������������������������������������������12 Cellular Microbiology ����������������������������������������������������������������������82 Clinical Infectious Diseases �������������������������������������������������������������86 Menschen / People Coinfection ��������������������������������������������������������������������������������������90 Sven Perner �������������������������������������������������������������������������������������16 Diagnostic Mycobacteriology (NRC) �����������������������������������������������94 Xinhua Yu & Gabriela Riemekasten ������������������������������������������������17 Immunobiophysics ��������������������������������������������������������������������������98 Katharina Kranzer ����������������������������������������������������������������������������18 Infection Immunology �������������������������������������������������������������������102 Katarzyna Duda �������������������������������������������������������������������������������19
    [Show full text]
  • When Allergies Go West
    OUTLOOK ALLERGIES erms can be good for us. This ‘hygiene hypothesis’ claims the urban ‘West- ern’ lifestyle, with its relatively limited Gexposure to infectious agents during child- hood, might be behind the post-war epi- JOE POLILLIO/GETTY demics of asthma, eczema and food allergies. But can the explosion in allergies in the devel- oped world really be explained so simply? A more complicated theory is emerging. For, while it is apparent that there is some- thing about Western living that increases the risk of developing allergies, research has shown that it’s not just a culture of antibacterial soaps, antibiotics and excessive cleanliness that’s to blame. There is evidence to suggest there is more about the way children are raised — where they are raised, what they are fed and how many siblings they have — that influences their burgeoning immune systems. It’s not just that their exposure to microbes or potential allergens seems to be limited. Sanitary liv- ing conditions disrupt the delicate balance between our bodies and a complex ecology of microbes and parasites with which we co- evolved, and through which our immune systems are balanced and regulated (see ‘Gut reaction’, page S5). In 1989, epidemiologist David Strachan proposed the theory that a reduced exposure to dirt could render a person prone to allergy. The idea originally had a far narrower scope and, as Strachan, then at the London School of Hygiene and Tropical Medicine, but now at St George’s University of London, is at pains to point out, he didn’t actually use the term ‘hygiene hypothesis’.
    [Show full text]
  • Indoor Bacterial Microbiota and the Development of Asthma by 10.5 Years of Age
    Journal Pre-proof Indoor Bacterial Microbiota and the Development of Asthma by 10.5 years of age Anne M. Karvonen, PhD, Pirkka V. Kirjavainen, PhD, Martin Täubel, PhD, Balamuralikrishna Jayaprakash, MSc, Rachel I. Adams, PhD, Joanne E. Sordillo, ScD, Diane R. Gold, MD, MPH, Anne Hyvärinen, PhD, Sami Remes, MD, MPH, Erika von Mutius, MD, Juha Pekkanen, MD PII: S0091-6749(19)31033-4 DOI: https://doi.org/10.1016/j.jaci.2019.07.035 Reference: YMAI 14123 To appear in: Journal of Allergy and Clinical Immunology Received Date: 7 September 2017 Revised Date: 6 June 2019 Accepted Date: 11 July 2019 Please cite this article as: Karvonen AM, Kirjavainen PV, Täubel M, Jayaprakash B, Adams RI, Sordillo JE, Gold DR, Hyvärinen A, Remes S, von Mutius E, Pekkanen J, Indoor Bacterial Microbiota and the Development of Asthma by 10.5 years of age, Journal of Allergy and Clinical Immunology (2019), doi: https://doi.org/10.1016/j.jaci.2019.07.035. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Inc.
    [Show full text]
  • Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk
    This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=18998 Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk ISBN Committee on Strategies for Responsible Sharing of Clinical Trial Data; 978-0-309-31629-3 Board on Health Sciences Policy; Institute of Medicine 280 pages 6 x 9 PAPERBACK (2015) Visit the National Academies Press online and register for... Instant access to free PDF downloads of titles from the NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL 10% off print titles Custom notification of new releases in your field of interest Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Request reprint permission for this book Copyright © National Academy of Sciences. All rights reserved. Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk Sharing Clinical Trial Data Maximizing Benefits, Minimizing Risk Committee on Strategies for Responsible Sharing of Clinical Trial Data Board on Health Sciences Policy PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright © National Academy of Sciences. All rights reserved. Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.
    [Show full text]
  • THELANCET-D-16-01609R2 Title: After Asthma
    Elsevier Editorial System(tm) for The Lancet Manuscript Draft Manuscript Number: THELANCET-D-16-01609R2 Title: After asthma - redefining airways diseases. A Lancet commission Article Type: Other Corresponding Author: Professor Ian Pavord, DM FRCP Corresponding Author's Institution: University of Oxford First Author: Ian D Pavord, FMedSci Order of Authors: Ian D Pavord, FMedSci; Richard Beasley, MD; Alvar Agusti, MD; Gary P Anderson, PhD; Elisabeth Bel, MD; Guy Brusselle, MD; Paul Cullinan, MD; Adnan Custovic, MD; Francine M Ducharme, MD; John V Fahy, MD; Urs Frey, MD; Peter Gibson, MD; Liam G Heaney, MD; Pat Holt, MD; Marc Humbert, MD; Clare Lloyd, PhD; Guy Marks, MD; Fernando D Martinez, MD; Peter D Sly, MD; Erika von Mutius, MD; Sally Wenzel, MD; Heather Zar, MD; Andrew Bush, MD Abstract: No abstract for this article type *Manuscript After asthma – redefining airways diseases. A Lancet commission Ian D Pavord1, Richard Beasley2, Alvar Agusti3, Gary P Anderson4, Elisabeth Bel5, Guy Brusselle6, Paul Cullinan7, Adnan Custovic8, Francine M Ducharme9, John V Fahy10, Urs Frey11, Peter Gibson12, Liam G Heaney13, Patrick G Holt14, Marc Humbert15, Clare Lloyd16, Guy Marks17, Fernando D Martinez18, Peter D Sly19, Erika von Mutius20, Sally Wenzel21, Heather J Zar22, Andy Bush8,23 1Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, UK; 2Medical Research Institute of New Zealand, Wellington, New Zealand ; 3Respiratory Institute, Hospital Clinic, IDIBAPS, Univ. Barcelona and CIBER Enfermedades Respiratorias (CIBERES),
    [Show full text]
  • Prevalence Ofasthma and Allergic Disorders Among Children in United
    Prevalence ofasthma and allergic disorders among children in united Germany: a descriptive comparison BMJ: first published as 10.1136/bmj.305.6866.1395 on 5 December 1992. Downloaded from Erika von Mutius, Christian Fritzsch, Stephan K Weiland, Gabriele Roll, Helgo Magnussen Abstract The reunification of Germany provided a unique Objectives-To compare the prevalence of opportunity to study two genetically similar popula- asthma and allergic disorders among children in tions who over the past 45 years have been exposed to Munich, western Germany, and Leipzig, eastern different living conditions and levels of environmental Germany, where environmental exposure, particu- pollution. In particular, the type of air pollution differs larly air concentrations of sulphur dioxide and greatly between westem and eastern Germany. The particulate matter, and living conditions have objective of this study was to compare the prevalences differed over the past 45 years. of asthma and allergic disorders among children in Design-Prevalence surveys among school- Munich, western Germany, and Leipzig, eastern children aged 9-11 years in Leipzig and Munich. Self Germany, where air concentrations of sulphur dioxide completion of written questionnaire by the child- are particularly high. A prevalence survey of 9-1 1 year ren's parents and lung function measurements. old children was carried out in both cities by the same Subjects-1051 children in Leipzig and 5030 in methods. Munich. Setting-Primary schools. Main outcome measures-Reported lifetime Subjects and methods prevalence of asthma and allergic disorders, and STUDY AREAS AND POPULATIONS bronchial hyperresponsiveness assessed by cold air Munich is a city with moderate industry and heavy inhalation challenge.
    [Show full text]